Morgan Stanley »

Akari Therapeutics Plc Sponsored shares owned by Morgan Stanley

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $16 6 2.67
2024-03-31 $10 6 1.83
2023-12-31 $25 8 3.13

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Akari Therapeutics Plc Sponsored

Omnia Family Wealth
Citadel Advisors
HPM Partners
Renaissance Technologies
Bank of America Corporation
Advisor Group Holdings
Morgan Stanley
Cornerstone Planning Group

View all funds holding Akari Therapeutics Plc Sponsored